Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial cell wall is a rigid, mesh-like structure composed primarily of peptidoglycan, a network of glycan (sugar) strands cross-linked by peptides, which provides mechanical strength and maintains cell shape while preventing osmotic lysis[1][2][3][4][5]. Peptidoglycan is synthesized by a series of enzymatic steps involving lipid intermediates (like lipid II), glycosyltransferases, and transpeptidases called penicillin-binding proteins (PBPs), which are essential for cell viability and division[1][5]. Associated proteins include a range of biosynthetic enzymes (Mur family, flippases, PBPs), some of which serve as major drug targets for well-established antibiotics (such as β-lactams and glycopeptides), where inhibition leads to cell death by weakening the wall structure[5][3][4]. The cell wall and its associated biosynthesis proteins are unique to bacteria, absent in human cells, making them highly important and specific therapeutic targets in infectious disease[3][4][5]. Note: - The term "Bacterial cell wall and protein" is overly broad and non-standard; for structured information and drug development purposes, split into: “Peptidoglycan” (the cell wall matrix) and precise “cell wall biosynthetic protein name” (e.g., Penicillin-binding protein 2), depending on context[1][5]. - Mechanisms and drugs vary depending on which particular protein or biosynthetic step is referenced (see above for major drugs and mechanisms). - Structural and biosynthetic proteins (such as PBPs, Mur enzymes, flippases) are typical direct molecular targets[1][5].
Inhibition of peptidoglycan cross-linking (β-lactams bind and inhibit penicillin-binding proteins; glycopeptides bind D-Ala-D-Ala termini of precursors) Blocking cell wall synthesis at early steps (fosfomycin, bacitracin) Disruption of cell wall integrity, leading to cell lysis
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peptidoglycan (bacterial cell wall) and associated biosynthetic proteins.